1. Home
  2. AMRX vs HUBG Comparison

AMRX vs HUBG Comparison

Compare AMRX & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • HUBG
  • Stock Information
  • Founded
  • AMRX 2002
  • HUBG 1971
  • Country
  • AMRX United States
  • HUBG United States
  • Employees
  • AMRX N/A
  • HUBG N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • HUBG Oil Refining/Marketing
  • Sector
  • AMRX Health Care
  • HUBG Consumer Discretionary
  • Exchange
  • AMRX Nasdaq
  • HUBG Nasdaq
  • Market Cap
  • AMRX 2.4B
  • HUBG 2.0B
  • IPO Year
  • AMRX N/A
  • HUBG 1996
  • Fundamental
  • Price
  • AMRX $7.36
  • HUBG $32.30
  • Analyst Decision
  • AMRX Strong Buy
  • HUBG Buy
  • Analyst Count
  • AMRX 5
  • HUBG 10
  • Target Price
  • AMRX $10.80
  • HUBG $47.30
  • AVG Volume (30 Days)
  • AMRX 2.0M
  • HUBG 765.6K
  • Earning Date
  • AMRX 05-02-2025
  • HUBG 05-08-2025
  • Dividend Yield
  • AMRX N/A
  • HUBG 1.55%
  • EPS Growth
  • AMRX N/A
  • HUBG N/A
  • EPS
  • AMRX N/A
  • HUBG 1.70
  • Revenue
  • AMRX $2,793,957,000.00
  • HUBG $3,946,390,000.00
  • Revenue This Year
  • AMRX $10.49
  • HUBG $5.26
  • Revenue Next Year
  • AMRX $7.00
  • HUBG $6.93
  • P/E Ratio
  • AMRX N/A
  • HUBG $19.00
  • Revenue Growth
  • AMRX 16.73
  • HUBG N/A
  • 52 Week Low
  • AMRX $5.18
  • HUBG $31.30
  • 52 Week High
  • AMRX $9.48
  • HUBG $53.21
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 40.90
  • HUBG 35.97
  • Support Level
  • AMRX $6.69
  • HUBG $31.30
  • Resistance Level
  • AMRX $7.29
  • HUBG $34.02
  • Average True Range (ATR)
  • AMRX 0.39
  • HUBG 1.83
  • MACD
  • AMRX -0.04
  • HUBG -0.13
  • Stochastic Oscillator
  • AMRX 35.71
  • HUBG 14.79

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HUBG Hub Group Inc.

Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset light truck brokerage operations, along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub is somewhat acquisitive in that it often makes tuck-in acquisitions which expand its brokerage, last-mile, and dedicated offerings.

Share on Social Networks: